Neil Callahan

## PROSPECT INFORMATION: Name: Neil Callahan Title: Founder & Managing Partner Fund: Pilot Growth Equity Background: Neil Callahan's LinkedIn activity includes several reshares from other users, demonstrating his engagement with content related to AI, healthcare, and business. On '2025-10-31', he reshared a post from 'r4 Technologies' discussing food rescue efforts, quoting their CEO, Paul Breitenbach: 'For too many families across New York, access to nutritious food remains an everyday challenge. Together with The Smart Food Foundation, we’re working to get healthy food to the people who need it most. This partnership reflects the power of collaboration in strengthening communities across the state.' On '2025-10-30', he reshared a post from Dennis A. Mitchell, DDS, MPH about the opening of the Alpha Leadership Institute, noting, 'An adolescent dream brought to life.' On '2025-10-21', another reshare from 'r4 Technologies' highlighted the critical role of technology in food security, quoting Paul Breitenbach: 'When 40 million Americans rely on SNAP, the question isn’t whether we can do better — it’s how.' On '2025-10-15', he reshared a humorous post from Uwe Graf about COBOL. A reshare from 'University of Chicago' on '2025-10-09' mentioned that 'Scholars affiliated with UChicago have earned a total of 101 Nobel Prizes, shaping our economy, science and culture for more than a century.' On '2025-09-30', he reshared a post emphasizing problem-solving over tools, with the questions: 'HOW will it solve a real Business Challenge? WHERE will it create the most Value? WHY do we need it Now?' On '2025-08-27', he reshared a post from 'Columbia University College of Dental Medicine' about their AI streamlining student scheduling. Also on '2025-08-27', he reshared a post from 'AvidXchange, Inc.' about AP automation. On '2025-08-17', he reshared a post from Parag Mamnani about challenges in e-commerce, advising, 'Don't hate the game, learn to play smarter.' On '2025-08-08', he reshared a post from Paul Breitenbach discussing AI's transformation of industries. On '2025-08-01', a reshare from Emanuel Petricoin expressed, 'It was wonderful and an honor to work with my colleagues Jeni, Aharon, Nelson and Nick on this effort!!!' On '2025-07-24', a reshare from Manlio Carrelli of 'CB Insights' discussed AI agents as 'revenue machines'. On '2025-07-18', he reshared a post from Parag Mamnani about widening context windows for teams and AI's impact. On '2025-07-05', two reshares from Alan McNab focused on WhatsApp for Business API's evolution and a philosophical take on the lasting power of old inventions, with the question: 'Why are some things that were invented a long time ago still used today? Maybe it's because we haven't come up with anything better since?' Later on '2025-07-05', another reshare from Parag Mamnani highlighted an AI hackathon at 'Webgility'. On '2025-06-27', Neil himself posted: 'What a great evening at the theater. As Alan McNab points out, we are all in sales: making promises, negotiating with our counterparty, getting in done, and following up, pretty much the nature of any human relationship. In other works, sales is really a collaboration satisfying the needs and wants of each party. Maybe coffee is for everyone, the customer and the closer?' On '2025-06-26', he reshared a post from Anand Sanwal of 'CB Insights' stating, 'Look mom! We’re on the cover of The Wall Street Journal CB Insights data illustrating private market trends and EU’s growing irrelevance.' Also on '2025-06-26', he reshared two posts from 'Perthera' and 'Webgility' celebrating their 'Hi-Flyers'. On '2025-05-29' he reshared a 'Perthera' post about their presence at 'ASCO 25' and a reshare from 'Irawan Mulyadi' congratulating 'PT. PathGen Diagnostik Teknologi and Perthera' on an MoU, quoting Indonesia's Minister of Health Budi Sadikin on AI: 'to fight against cancer not just harder but smarter. Cancer healing not just with drugs but with data, purpose and belief. To transform cancer treatment from reaction to revelation.' Also on '2025-05-25', he reshared 'Perthera' announcing their partnership with 'PT. PathGen Diagnostik Teknologi'. On '2025-05-14', he reshared a post from 'Kaptea' about SIGNALCONF and from 'Irawan Mulyadi' again congratulating the 'Perthera' partnership. On '2025-04-29', he reshared a post from 'Roboteam' with their CEO testing a product. On '2025-04-04', he reshared a post from Anand Sanwal of 'CB Insights', stating 'Velocity wins' and highlighting their product enhancements. On '2025-04-01', he reshared a post about preparedness from Vasco Botelho. On '2025-03-29', he reshared a post from Parag Mamnani about automating accounting and inventory for 'Mighty Hydro'. On '2025-03-15', he reshared a post from Mona Marquardt celebrating 'InRider Partners' 5th anniversary. He also reshared a post about pancreatic cancer outcomes from Patricia De Arbeloa MD,MS and from Parag Mamnani about 'Webgility's' new features for Shopify Plus B2B sellers. On '2025-02-27', he reshared a post from Anand Sanwal appreciating 'CB Insights' LLM capabilities and from 'Perthera' announcing 'the discovery of the world's first AI-driven Chemotherapy predictor for the frontline treatment of pancreatic adenocarcinoma (PDAC).' On '2025-02-12', he reshared a post from Jon Sakoda lamenting the passing of Dick Kramlich, founder of NEA, noting his mentorship and belief 'in the magic of Silicon Valley'. On '2025-02-09', he reshared a 'Perthera' post about their work featured in ASCO GI's Poster Walk, discussing 'Validation of the PDACai signature in predicting relative benefit from frontline FOLFIRINOX (FFX) and gemcitabine/nab-paclitaxel (GA)'. On '2025-02-02', he reshared the same 'Perthera' post. On '2025-01-16', Neil posted 'Congratulations Jon!' referencing an article about Alium's seed funding. On '2025-01-15', he reshared a Perthera post announcing their 'AI-driven Chemo Predictor for Frontline Treatment of Pancreatic Adenocarcinoma (PDAC)' and posted a link to an article about it. On '2025-01-10', he reshared a post about Meta copying features and another from Pablo Fernandez Alvarez discussing Satya Nadella's vision for the future of SaaS, quoting him: 'The business logic is all going to these AI agents. They’re not going to discriminate between what the backend is — they’ll update multiple databases, and all the logic will be in the AI tier.' On '2024-12-22', he reshared a 'Perthera' post about lung vs. liver metastasis in pancreatic cancer. On '2024-12-14', he reshared a post from Anand Sanwal of 'CB Insights' about their market intelligence being available in Microsoft Copilot. On '2024-12-10', he reshared a post from Donna Tuths about healthcare AI and its potential to improve outcomes. On '2024-11-26', he reshared a post from Donna Tuths about 'Perthera' enhancing their 'AI learning component' and stated: 'We are excited to further enhance the AI learning component of our oncology therapeutic intelligence engine. Our unique combination of expert scientists and doctors with an AI-powered analytic engine delivers a better solution, and better outcomes for cancer patients. It's the absolutely best journey to be on.' On '2024-11-25', he reshared a post from Manlio Carrelli of 'CB Insights' about their integration with Microsoft Copilot. Fund details: - Description: Pilot Growth Equity is a technology growth equity firm with offices in San Francisco and New York. Pilot Growth invests in growth-stage technology companies that require capital and strategic resources to accelerate their growth. Founded by entrepreneurs, Pilot Growth provides its portfolio companies a combination of world class operating, company-building, and advisory expertise, as well as global access to private and public sector customers. Please visit us at www.pilotgrowth.com. - Website: http://www.pilotgrowth.com - Location: San Francisco, California, United States - Lead qualification: 70/100 - Immediate priority: Perfect fit profile (growth equity, ideal team size, strong AUM) but deal activity suggests sourcing challenges that AI deal flow could solve Use case: Deliver 30 qualified growth-stage B2B SaaS companies monthly with $5-50M revenue, 30%+ growth rates, and founder/CEO contacts ready for direct outreach Pain points: • No new portfolio investments documented in 2023-2024 despite active fund • Small 11-person team limits market coverage across multiple tech verticals • Operating in competitive SF/NYC markets where larger firms outspend on sourcing decision_maker: Neil Callahan, Founder & Managing Partner portfolio_count: 14 companies - Recent deals: • CB Information Services exit (October 2024) • Bizzabo Series D (2019-2022) - Event management SaaS platform, $15M+ • Cujo AI - Cybersecurity SaaS platform for network operators • Perthera (2016) - Precision cancer analysis, $8.7M Research: - Query: Pilot Growth Equity (web (Neil Callahan) recent investments? fund focus / thesis? - Answer: Pilot Growth Equity focuses on early-stage investments in healthcare and technology. Neil Callahan is a Managing Director with a focus on $10M deals. The fund primarily targets healthcare and technology sectors.